Time to insulin after failure of oral antidiabetic therapy in type 2 diabetes: A UK population-based analysis

Aug-06

Endocrinology

AUTHORS : Dr Annalisa Rubino (Details for study: RTI Health Solutions), Astrazeneca, Cambridge, United Kingdom – Email: annalisa.rubino@astrazeneca.com

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 15(S1):S51

DOI : 10.1002/pds.1295

Read more